Sohini Das, Business Standard

Stories by Sohini Das, Business Standard

Electric scooters set to dominate India's two-wheeler market by 2037, outpacing motorcycles

Electric scooters set to dominate India's two-wheeler market by 2037, outpacing motorcycles

Rediff.com   4 days ago

India's two-wheeler market is on the cusp of a significant transformation, with electric scooters projected to surpass motorcycles in volume terms within the next decade, driven by urbanisation, increased female workforce participation, and the accelerating shift towards electrification, according to an Equirus Securities report.

Tata Motors leads PV recovery in H2

Tata Motors leads PV recovery in H2

Rediff.com   5 days ago

Tata Motors emerged as the biggest gainer in the passenger vehicles (PV) market in the second half of FY25, following a GST rate cut in September, achieving the highest growth among major OEMs and overtaking Mahindra & Mahindra in volumes.

After GST-led surge, car sales growth may decelerate in FY27

After GST-led surge, car sales growth may decelerate in FY27

Rediff.com   5 days ago

India's passenger vehicle (PV) industry is projected to experience moderated growth in FY27, following a strong rebound in H2FY26, primarily due to the high base effect, absorbed pent-up demand, and the lingering impact of geopolitical tensions in West Asia.

Top end luxury cars power Mercedes over entry-level models

Top end luxury cars power Mercedes over entry-level models

Rediff.com   5 days ago

What we will not do is discount deeply, neither will we compromise on product substance, says Managing Director and Chief Executive Officer (MD&CEO) Santosh Iyer.

Tesla Stalls in India as BYD, VinFast Race Ahead

Tesla Stalls in India as BYD, VinFast Race Ahead

Rediff.com   10 Apr 2026

Despite India's electric passenger vehicle market experiencing an 83.6% year-on-year surge in FY26, new foreign entrants VinFast and BYD have significantly outpaced Tesla, which struggles with high import duties, a limited retail footprint, and a lack of local manufacturing commitment.

Indian Pharma Market Records Strongest Q4 Growth in Five Quarters

Indian Pharma Market Records Strongest Q4 Growth in Five Quarters

Rediff.com   9 Apr 2026

India's domestic pharmaceutical market recorded its highest value growth in five quarters during Q4 FY26, driven primarily by pricing and an early indication of volume recovery, with a significant structural shift towards chronic and sub-chronic therapies.

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Biocon eyes global insulin leadership as rivals pivot to GLP-1 therapies

Rediff.com   8 Apr 2026

Biocon aims to become the world's leading insulin company, capitalising on larger pharmaceutical rivals' strategic shift towards newer, high-margin GLP-1 diabetes therapies. The company plans to expand its insulin presence across 80 markets, focusing on value maximisation and addressing the indispensable need for insulin, particularly for Type-1 and late-stage Type-2 diabetics.

Jio IPO Set To Break All Records

Jio IPO Set To Break All Records

Rediff.com   4 Apr 2026

Only 2.5 per cent of the equity in Jio Platforms will be offloaded through the OFS route -- meant for secondary share sale.

Goldman Cuts India Market Outlook

Goldman Cuts India Market Outlook

Rediff.com   27 Mar 2026

Goldman Sachs has materially lowered its earnings growth forecast for Indian companies by a cumulative 9 percentage points over the next two years.

Hiring Outlook Brightens for FY27

Hiring Outlook Brightens for FY27

Rediff.com   26 Mar 2026

Hiring demand strongest in ecommerce, tech startups, healthcare, and energy sectors, with Bengaluru, Hyderabad, and Pune leading.

'No Governance Issue In HDFC Bank'

'No Governance Issue In HDFC Bank'

Rediff.com   20 Mar 2026

'Being an important institution in the banking system, we are subject to regulatory supervision, both offsite and onsite.' 'When you look at the intensity at which these levels of supervision come, we, on the board and in management, believe there should not be any surprises.'

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Multinational pharma cos, Indian drugmakers diverge to mutual gain: How win-win is it?

Rediff.com   11 Mar 2026

For decades, multinational pharmaceutical companies and Indian drugmakers worked in ways that supported each other: MNCs brought innovation and brands, while Indian companies built scale through generics and cost efficiency. There was an important overlap - generic drugs - but this is shrinking fast. And the consequences are reshaping India's gigantic pharmaceutical market.

India wages war on cervical cancer with free HPV vax for girls

India wages war on cervical cancer with free HPV vax for girls

Rediff.com   6 Mar 2026

The figures are grim. India accounts for around 19 per cent of global cervical cancer cases and 23 per cent of deaths.

Why ICE Still Rules India's Car Market

Why ICE Still Rules India's Car Market

Rediff.com   27 Feb 2026

Indian car buyers care more about affordability than technology, keeping ICE vehicles dominant while hybrids emerge as the preferred transition option and EVs struggle in the mass market.

'You End Up Firefighting': Finance Minister

'You End Up Firefighting': Finance Minister

Rediff.com   26 Feb 2026

'Uncertainty level A in the morning, uncertainty level B in the afternoon. If I answer about tariff rates now, I'll be outdated by the evening.'

AI is fast becoming central to how drugs will be discovered

AI is fast becoming central to how drugs will be discovered

Rediff.com   25 Feb 2026

Artificial intelligence (AI) is no longer a side conversation for Indian pharma. It is fast becoming central to how drugs will be discovered, made, and supplied. Along with that shift comes a sharper focus on innovation, on the one hand, and quality and trust, on the other.

'India Is A Reverse AI Trade Globally'

'India Is A Reverse AI Trade Globally'

Rediff.com   25 Feb 2026

'The day that the market realises that they've overspent (on AI) and there's a sudden collapse in the capex, then India can start outperforming again.'

Skoda Eyes Cleaner Fuel Options as Kylaq Drives New Buyers

Skoda Eyes Cleaner Fuel Options as Kylaq Drives New Buyers

Rediff.com   23 Feb 2026

Skoda India is focusing on cleaner fuel options, including CNG and EVs, while compact SUV Kylaq drives volumes, expands first-time buyers and strengthens the brand in India's competitive market

AI Can Make India World's Creative Capital

AI Can Make India World's Creative Capital

Rediff.com   21 Feb 2026

'Not the back office for the world's content. The leader. The standard-setter.'

Cheaper Harleys Likely To Test Enfield's Pricing Power

Cheaper Harleys Likely To Test Enfield's Pricing Power

Rediff.com   19 Feb 2026

The tariff removal will lower prices of Harley's large-displacement imported motorcycles, which retail between 14.5 lakh and 45.8 lakh but after the duty cut volumes are expected to remain modest.